FDA ‘Encouraged’ By Industry Response To Guidance 213

by | Mar 25, 2014 | News | 0 comments

On December 12, 2013, the Food and Drug administration asked the animal pharmaceutical industry to notify the agency in writing within 90 days of its intent to engage with the FDA as defined in Guidance 213. This request made by the FDA is another part of the plan to help phase out the use of medically important antimicrobials in food animals for food production purposes. As of March 12, 2014, the FDA stated that it has received responses from all the sponsors affected by Guidance 213 and they are in the process of reviewing and analyzing the responses. The response so far has been positive and encouraging to the agency. Read more here about how the industry is responding to Guidance 213.

Recent GVL Blog Posts

Thanksgiving Holiday Hours

Thanksgiving Holiday Hours

The GVL office will be closed Thursday, November 26, 2020 and Friday, November 27, 2020. Normal support hoursThe GVL Customer Success Team is available via chat, email or phone every day from 7:00 a.m. to 7:00 p.m. central time. Call 515-817-5704 or email...

Join us at the virtual AAEP Annual Convention

Join us at the virtual AAEP Annual Convention

We're excited to connect with you at the virtual AAEP Annual Convention, where we'll be sharing: Extended Equine CVI progress Improvements to our EIA tests GVL updates and news Giveaways, of course The Virtual Convention is an educational and networking event held...

Newport Laboratories, Inc. Re-Launches HerdPoint™ in GVL®

Newport Laboratories, Inc. Re-Launches HerdPoint™ in GVL®

Improved veterinary software for custom-made vaccine management now included in GVL platform Ames, Iowa (Nov. 20, 2020) – Veterinarians can now manage animal health and movement documents and vaccine isolates in the GVL platform with HerdPoint, a custom-made vaccine...